The epidemiology of complications

[1] Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor [J]. DIABETES, 1997, 46 (09) : 1473 - 1480

[2] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487

[3] The impact of the Diabetes Control and Complications Trial and Humalog insulin or glycohemoglobin levels and severe hypoglycemia in type 1 diabetes [J]. DIABETES CARE, 2001, 24 (03) : 430 - 434

[4] Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) : 370 - 379

[5] Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J]. LANCET, 1998, 351 (9095) : 28 - 31

[6] Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold [J]. KIDNEY INTERNATIONAL, 2001, 60 (01) : 219 - 227

[7] Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy - Early treatment diabetic retinopathy study (ETDRS) report 22 [J]. ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (09) : 1079 - 1084

[8] The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2160 - 2167

[9] Friedman EA, 1999, DIABETES CARE, V22, pB65

[10] Dietary glycotoxins - Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration [J]. DIABETES, 1999, 48 (06) : 1308 - 1315

[1] Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor [J]. DIABETES, 1997, 46 (09) : 1473 - 1480

[2] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487

[3] The impact of the Diabetes Control and Complications Trial and Humalog insulin or glycohemoglobin levels and severe hypoglycemia in type 1 diabetes [J]. DIABETES CARE, 2001, 24 (03) : 430 - 434

[4] Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) : 370 - 379

[5] Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J]. LANCET, 1998, 351 (9095) : 28 - 31

[6] Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold [J]. KIDNEY INTERNATIONAL, 2001, 60 (01) : 219 - 227

[7] Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy - Early treatment diabetic retinopathy study (ETDRS) report 22 [J]. ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (09) : 1079 - 1084

[8] The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2160 - 2167

[9] Friedman EA, 1999, DIABETES CARE, V22, pB65

[10] Dietary glycotoxins - Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration [J]. DIABETES, 1999, 48 (06) : 1308 - 1315